Human Internal BIOASTER's Samples Collection

NCT06602388 — Not yet recruiting, 120 participants, Bioaster

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Non-interventional, Monocentric Study Aimed at Building up a Collection of Biological Samples Collected From Bioaster Collaborators for Scientific Purposes

RegistryNCT06602388, acronym HIBISCUS
StatusNot yet recruiting
Study typeObservational
Enrollment120 (Estimated)
SponsorBioaster (Other)
ConditionsBiological Samples
InterventionsBiological sampling (Other)
Datesstart 2024-12-30 (estimated), primary completion 2027-12-31 (estimated), completion 2027-12-31 (estimated), first posted 2024-09-19, last updated 2024-09-20

Related Papers Related Patents Related Grants Related Experts
All trials for Biological Samples All trials of Biological sampling

-Summary

BIOASTER is a Technological Research Institute dedicated to microbiology and infectious diseases. BIAOSTER s areas of expertise are organized around four research programs: 1/ Antimicrobials; 2/ Vaccines; 3/ Microbiota; 4/ Diagnostics.

Hibiscus is a non-interventional, monocentric study aimed at building up a a collection of biological samples (stool, urine, saliva, buccal swab, nasal swab, superficial skin swab, hair) collected from BIOASTER employees. These samples to be used for scientific purposes including the technological development of Bioaster s collaborative and in-house research projects.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Healthy volunteers (Bioaster employees)Other: Biological samplingCollection of biological samples from healthy volunteers: Stool, urine, saliva, buccal swab, nasal swab, superficial skin swab, hair
  • Biological sampling (Other): Collection of biological samples from healthy volunteers: Stool, urine, saliva, buccal swab, nasal swab, superficial skin swab, hair

+Outcome measures

Primary outcomes

  • The number of analyzable samples collected for scientific purposes. [3 years after the first inclusion]: The number of analyzable samples collected for scientific purposes at the end of inclusion periode

+Eligibility

Sex: All, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

Some inclusion criteria can be defined according to the needs of the scientific objective. For example, it is up to volunteers to decide whether or not to participate if they meet the following criteria:

* Age criteria (e.g.: specific, non-identifying range sought: 30-40 years)
* BMI criteria (for example: BMI between 18.5 and 29 kg/m2)
* Gender criteria (e.g.: women only)

Exclusion Criteria:

Some of the following non-inclusion criteria may be defined according to the needs of the project:

* Minor subject
* Health criteria (e.g. presence or absence illness/infection/vaccination/allergy/anti-infective treatment in the last 3 months prior to the date of sampling)
* Smoker status
* Severe chronic illness (active cancer, HIV, severe renal failure, ongoing severe heart, liver or biliary disorders, arthritis)
* Diagnosed acute or chronic gastrointestinal disease or complication (e.g. celiac disease, gastroesophageal reflux, gastric or duodenal ulcer, Crohn\'s disease, hemorrhoids, irritable bowel syndrome),

In all cases, it will be requested that volunteers with the following criteria do not participate in the study:

* Pregnant or breast-feeding women
* Subjects under curatorship or guardianship
* Subjects under legal protection.

+Investigators

  • Cyril GUYARD, Study Director, Study director, Bioaster
  • Dr Xavier MORGE, Principal investigator, Bioaster